Communication

OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET

Communication, Forward-looking statement
Tuesday, July 27, 2021 - 1:00pm

Connecting over half of healthcare providers in theU.S.and millions of patients through a proprietary network, theOptimizeRxdigital health platform helps patients afford and stay on medications.

Key Points: 
  • Connecting over half of healthcare providers in theU.S.and millions of patients through a proprietary network, theOptimizeRxdigital health platform helps patients afford and stay on medications.
  • The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.
  • Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
  • The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other material risks.

Nanox to Announce Second Quarter 2021 Financial and Operating Results on Tuesday, August 10, 2021

Communication, Forward-looking statement
Tuesday, July 27, 2021 - 1:00pm

Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.

Key Points: 
  • Nanox believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all.
  • This press release may contain forward-looking statements that are subject to risks and uncertainties.
  • All statements that are not historical facts contained in this press release are forward-looking statements.
  • Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Nanox's expectations.

iSpecimen to Report Second Quarter 2021 Results on August 10, 2021

Finance, Money, Economy, Communication, Forward-looking statement, Biobanks, Investor, Biological specimen
Tuesday, July 27, 2021 - 12:00pm

Participants must use the following code to access the replay of the call: 13721607.

Key Points: 
  • Participants must use the following code to access the replay of the call: 13721607.
  • An archived version of the webcast will also be available on iSpecimen's Investor Relations site: https://ispecimen.irpass.com/ .
  • iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery.
  • Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," believe," "estimate" and "continue" or similar words.

Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021

Biotechnology, Health, Clinical trials, Other Health, Medical specialties, Branches of biology, Clinical medicine, Immunology, Antibodies, Chemical pathology, Communication, Forward-looking statement, Anti-SSA/Ro autoantibodies, Vaccine
Tuesday, July 27, 2021 - 11:00am

Biodesix is the first company to offer seven non-invasive tests for patients with diseases of the lung, including three proteomic tests.

Key Points: 
  • Biodesix is the first company to offer seven non-invasive tests for patients with diseases of the lung, including three proteomic tests.
  • The antibody tests can detect antibodies that are generated both from infection by the virus and from the vaccines.
  • Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors.
  • Biodesix undertakes no obligation to revise or publicly release the results of any revision to such forward-looking statements, except as required by law.

IAS Teams with The Global Disinformation Index to Transform How Brands Avoid Misinformation

Disinformation, Deception, Media manipulation, Integral Ad Science, Propaganda techniques, Communication, Global Disinformation Index, Misinformation
Tuesday, July 27, 2021 - 11:00am

NEW YORK, July 27, 2021 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, today announced a new partnership with The Global Disinformation Index (GDI), making IAS the first ad verification company to help marketers avoid misinformation content based on GDI's standards.

Key Points: 
  • NEW YORK, July 27, 2021 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, today announced a new partnership with The Global Disinformation Index (GDI), making IAS the first ad verification company to help marketers avoid misinformation content based on GDI's standards.
  • With the rise of brand risk globally, we're providing highly advanced tools for marketers to safeguard their brands and avoid misinformation content," said Lisa Utzschneider, CEO, Integral Ad Science.
  • IAS is committed to helping marketers manage brand risk with the latest tools available and this new partnership with The Global Disinformation Index offers critical new capabilities.
  • The Global Disinformation Index is a not-for-profit that operates on the three principles of neutrality, independence and transparency.

Mvix and Simply NUC Partner to Launch an Affordable, Fully-Customizable, Enterprise-Grade Digital Signage Solution

Signage, Digital media, Digital signage, Video, Nuc, Visual arts, Nuc, Communication
Tuesday, July 27, 2021 - 10:00am

STERLING, Va., July 27, 2021 /PRNewswire/ --Mvix, a leading provider of enterprise-grade digital signage solutions , has partnered with Simply NUC, a state-of-the-art mini-PC company, to provide an affordable, fully-integrated digital signage solution.

Key Points: 
  • STERLING, Va., July 27, 2021 /PRNewswire/ --Mvix, a leading provider of enterprise-grade digital signage solutions , has partnered with Simply NUC, a state-of-the-art mini-PC company, to provide an affordable, fully-integrated digital signage solution.
  • As a part of this partnership, Mvix and Simply NUC will provide ready-to-use, enterprise-grade mini-PCs preloaded with fully-licensed Mvix digital signage software.
  • "This new partnership between Mvix and Simply NUC brings the best-in-class systems together for the digital signage world.
  • "We've seen the digital signage industry rapidly grow with opportunities in many different sectors and are thrilled to partner with Mvix to offer ready-to-use signage solutions," stated Aaron Rowsell, CEO at Simply NUC.

Hyloris to Report 2021 Half-Year Results on 4 August 2021

Communication, Forward-looking statement
Tuesday, July 27, 2021 - 6:00am

The webcast may be accessed on the Events page of the companys website or by clicking here .

Key Points: 
  • The webcast may be accessed on the Events page of the companys website or by clicking here .
  • Hyloris is a specialty biopharma company focused on innovating, reinventing, and optimising existing medications to address important healthcare needs and deliver relevant improvements for patients, healthcare professionals and payors.
  • Hyloris has built a broad, patented portfolio of 13 reformulated and repurposed value-added medicines that have the potential to offer significant advantages over available alternatives.
  • The Company undertakes no obligation to publicly update or revise forward-looking statements, except as may be required by law.

Tri Capital Opportunities Corp. Provides Update on Proposed Name Change and Qualifying Transaction

Communication, Forward-looking statement
Monday, July 26, 2021 - 5:23pm

Trading in the securities of a capital pool company should be considered highly speculative.

Key Points: 
  • Trading in the securities of a capital pool company should be considered highly speculative.
  • Risks and uncertainties exist that may cause actual results to differ materially from those indicated or implied in the forward-looking statements and information.
  • Readers should not place undue importance on forward looking information and should not rely upon this information as of any other date.
  • While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable laws.

Saint Jean Carbon Announces Option Grants

Communication, Forward-looking statement, Option
Monday, July 26, 2021 - 1:53pm

CALGARY, Alberta, July 26, 2021 (GLOBE NEWSWIRE) -- Saint Jean Carbon Inc. (Saint Jean or the Company) (TSX-V: SJL) announces that it has granted an aggregate of 2,350,000 options (the Options), of which 1,600,000 Options have been granted to a current Director of the Company, pursuant to the Companys stock option plan.

Key Points: 
  • CALGARY, Alberta, July 26, 2021 (GLOBE NEWSWIRE) -- Saint Jean Carbon Inc. (Saint Jean or the Company) (TSX-V: SJL) announces that it has granted an aggregate of 2,350,000 options (the Options), of which 1,600,000 Options have been granted to a current Director of the Company, pursuant to the Companys stock option plan.
  • FORWARD LOOKING STATEMENTS: This press release contains forward-looking statements, within the meaning of applicable securities legislation, concerning Saint Jeans business and affairs.
  • A number of factors, including those discussed above, could cause actual results to differ materially from the results discussed in the forward-looking statements.
  • Forward-looking information is provided as of the date of this press release, and Saint Jean assumes no obligation to update or revise them to reflect new events or circumstances, except as may be required under applicable securities legislation.

Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

Communication, Forward-looking statement
Monday, July 26, 2021 - 1:30pm

"We are delighted to have Dr. Tyle join Skyes board of directors.

Key Points: 
  • "We are delighted to have Dr. Tyle join Skyes board of directors.
  • We believe his broad leadership experience will prove invaluable as we advance our lead clinical program and execute strategies to expand our development portfolio, said Punit Dhillon, Chief Executive Officer and Chair of Skye Bioscience.
  • With expertise originating from a deep scientific foundation, Praveen has extensive cross-functional experience working with companies at various stages spanning big pharma through start-up biotech.
  • Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.